XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income $ 102,855 $ 133,881
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 8,440 9,101
Stock-based compensation expense 5,247 6,515
Inventory impairments and abandonments 616 935
Deferred and other income tax expense 15,466 29,683
Loss (gain) on disposal of fixed assets 1,178 (252)
Change in allowance for doubtful accounts 0 (6)
Loss on extinguishment of debt, net 533 78
Changes in operating assets and liabilities:    
Decrease in accounts receivable 2,695 554
Decrease in income tax receivable 9,987 0
Increase in inventory (1,228) (351,424)
Increase in other assets (5,346) (4,614)
(Decrease) increase in trade accounts payable (6,828) 12,473
Decrease in other liabilities (37,783) (1,428)
Net cash provided by (used in) operating activities 95,832 (164,504)
Cash flows from investing activities:    
Capital expenditures (14,122) (11,192)
Proceeds from sale of fixed assets 143 257
Purchases of investment securities (7,838) 0
Other (2) 0
Net cash used in investing activities (21,819) (10,935)
Cash flows from financing activities:    
Repayment of debt (4,998) (7,750)
Repayment of borrowings from credit facility 0 (80,000)
Borrowings from credit facility 0 80,000
Debt issuance costs (2,575) 0
Repurchase of common stock 0 (2,527)
Tax payments for stock-based compensation awards (2,615) (6,631)
Stock option exercises 12 5
Net cash used in financing activities (10,176) (16,903)
Net increase (decrease) in cash, cash equivalents, and restricted cash 63,837 (192,342)
Cash, cash equivalents, and restricted cash at beginning of period 251,828 274,143
Cash, cash equivalents, and restricted cash at end of period $ 315,665 $ 81,801